34223-82-0Relevant articles and documents
-
Huntress,Atkinson
, p. 1514,1516 (1936)
-
MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF
-
, (2021/01/23)
The disclosure relates to compounds and pharmaceutical compositions capable of modulating the hydroxysteroid 17-beta dehydrogenase (HSD17B) family member proteins including inhibiting the HSD17B member proteins, e.g. HSD17B13. The disclosure further relates to methods of treating liver diseases, disorders, or conditions with the compounds and pharmaceutical compositions disclosed herein, in which the HSD17B family member protein plays a role.
A Convenient Route to 3,6-Diaminofluoren-9-ones
Guinot, Stephane G. R.,Hepworth, John D.,Wainwright, Mark
, p. 1252 - 1261 (2007/10/03)
-